Therapeutic Advances in Medical Oncology

This journal is a member of the Committee on Publication Ethics (COPE).

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Medical Oncology (TAM) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the oncology community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/tao.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.

The APC for this journal is currently $3200 USD. The article processing charge for Plain Language Summary is $5000 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.

This journal flipped to open access on September 1, 2016.

Please direct any queries to oncology@sagepub.co.uk.